Austrobailignan 6
CAS 107534-93-0
Austrobailignan 6 (CAS 107534-93-0) is a pharmaceutical compound with 4 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 28982.952631578944 nM | 19 | - |
| - | IC50 | 40715 nM | 4 | - |
| - | AC50 | 5943.5 nM | 2 | - |
| - | EC50 | 53000 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Austrobailignan 6 used for in pharmaceutical contexts?
Austrobailignan 6 (CAS 107534-93-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Austrobailignan 6?
No adverse-event association or SIDER side-effect rows are rendered for Austrobailignan 6 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Austrobailignan 6 also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Macelignan with EU status "prohibited".
What clinical phase is Austrobailignan 6 in?
No phase 1-4 clinical development badge is rendered for Austrobailignan 6 because the matched compound identifier rows do not contain a max-phase value.